# The REPLACE Registry for Cholbam® (Cholic Acid)

> **NCT03115086** · — · ACTIVE_NOT_RECRUITING · sponsor: **Mirum Pharmaceuticals, Inc.** · enrollment: 55 (estimated)

## Conditions studied

- Bile Acid Synthesis Disorders

## Interventions

- **DRUG:** Cholbam

## Key facts

- **NCT ID:** NCT03115086
- **Lead sponsor:** Mirum Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-07-10
- **Primary completion:** 2038-07
- **Final completion:** 2039-07
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2023-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03115086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03115086, "The REPLACE Registry for Cholbam® (Cholic Acid)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03115086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*